Acadia Pharmaceuticals (ACAD) Shares Outstanding (Diluted) (2010 - 2026)

Acadia Pharmaceuticals (ACAD) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Acadia Pharmaceuticals 4.86 Bn 3.90 Bn 279.64 Mn 172.85 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 172.85 Mn
Mar 31, 2026 172.71 Mn
Dec 31, 2025 169.92 Mn
Sep 30, 2025 170.65 Mn
Jun 30, 2025 168.68 Mn
Mar 31, 2025 167.67 Mn
Dec 31, 2024 166.36 Mn
Sep 30, 2024 166.18 Mn
Jun 30, 2024 166.17 Mn
Mar 31, 2024 166.62 Mn
Dec 31, 2023 163,819.00
Sep 30, 2023 164,234.00
Jun 30, 2023 165,046.00
Mar 31, 2023 162.26 Mn
Dec 31, 2022 161,683.00
Sep 30, 2022 161,852.00
Jun 30, 2022 161,654.00
Mar 31, 2022 161.23 Mn
Dec 31, 2021 160,493.00
Sep 30, 2021 160,663.00